Chronic Lymphocytic Leukemia — Trials

Chronic Lymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 265
Recruiting: 124
Ph III recruiting: 16
Growth YoY: −16.3%
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (239)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00524667	HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia	terminated	Phase 2	6	CancerCare ManitobaOTHER	1	Jul 20, 2011	clinicaltrials
NCT01125787	Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab	terminated	Phase 2	1	Nevada Cancer InstituteOTHER	1	Jul 20, 2011	clinicaltrials